Sit Investment Associates Inc Dexcom Inc Transaction History

Sit Investment Associates Inc

$4.48 Billion
Q3 2024

A detailed history of Sit Investment Associates Inc transactions in Dexcom Inc stock. As of the latest transaction made, Sit Investment Associates Inc holds 134,716 shares of DXCM stock, worth $10.8 Million. This represents 0.2% of its overall portfolio holdings.

Number of Shares

134,716

Previous 128,757 4.63%

Holding current value

$10.8 Million

Previous $14.6 Million 38.14%

% of portfolio

0.2%

Previous 0.34%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$64.0 - $116.06 $381,376 - $691,601	5,959 Added 4.63%	134,716 $9.03 Million
Q2 2024 Aug 14, 2024	BUY	$110.31 - $140.45 $97,844 - $124,579	887 Added 0.69%	128,757 $14.6 Million
Q1 2024 May 14, 2024	SELL	$114.22 - $140.1 $20,559 - $25,218	-180 Reduced 0.14%	127,870 $17.7 Million
Q4 2023 Feb 13, 2024	SELL	$75.49 - $124.16 $683,561 - $1.12 Million	-9,055 Reduced 6.6%	128,050 $15.9 Million
Q3 2023 Nov 13, 2023	BUY	$86.06 - $137.93 $139,589 - $223,722	1,622 Added 1.2%	137,105 $12.8 Million
Q2 2023 Aug 10, 2023	BUY	$112.47 - $130.98 $54,660 - $63,656	486 Added 0.36%	135,483 $17.4 Million
Q1 2023 May 11, 2023	SELL	$104.0 - $122.92 $221,416 - $261,696	-2,129 Reduced 1.55%	134,997 $15.7 Million
Q4 2022 Feb 10, 2023	BUY	$84.98 - $122.67 $345,528 - $498,776	4,066 Added 3.06%	137,126 $15.5 Million
Q3 2022 Nov 10, 2022	SELL	$76.35 - $94.18 $56,880 - $70,164	-745 Reduced 0.56%	133,060 $10.7 Million
Q2 2022 Aug 11, 2022	BUY	$67.99 - $132.89 $6.87 Million - $13.4 Million	101,028 Added 308.23%	133,805 $9.97 Million
Q1 2022 May 12, 2022	BUY	$94.08 - $130.2 $5,927 - $8,202	63 Added 0.19%	32,777 $16.8 Million
Q4 2021 Feb 11, 2022	BUY	$129.87 - $162.82 $208,571 - $261,488	1,606 Added 5.16%	32,714 $17.6 Million
Q3 2021 Nov 12, 2021	SELL	$106.71 - $143.18 $339,978 - $456,171	-3,186 Reduced 9.29%	31,108 $17 Million
Q2 2021 Aug 13, 2021	SELL	$80.99 - $107.93 $43,005 - $57,310	-531 Reduced 1.52%	34,294 $14.6 Million
Q1 2021 May 13, 2021	BUY	$84.79 - $104.74 $31,796 - $39,277	375 Added 1.09%	34,825 $12.5 Million
Q4 2020 Feb 11, 2021	BUY	$78.0 - $104.5 $537,420 - $720,005	6,890 Added 25.0%	34,450 $12.7 Million
Q3 2020 Nov 12, 2020	SELL	$95.51 - $112.95 $985,185 - $1.17 Million	-10,315 Reduced 37.83%	16,950 $2.53 Million
Q3 2020 Nov 12, 2020	BUY	$95.51 - $112.95 $1.01 Million - $1.2 Million	10,610 Added 62.6%	27,560 $11.4 Million
Q2 2020 Aug 13, 2020	SELL	$62.68 - $105.34 $249,153 - $418,726	-3,975 Reduced 12.72%	27,265 $11.1 Million
Q1 2020 May 13, 2020	BUY	$47.79 - $75.63 $6,212 - $9,831	130 Added 0.42%	31,240 $8.41 Million
Q4 2019 Feb 13, 2020	BUY	$36.62 - $57.29 $518,539 - $811,226	14,160 Added 83.54%	31,110 $6.81 Million
Q3 2019 Nov 13, 2019	BUY	$35.53 - $43.8 $87,048 - $107,310	2,450 Added 16.9%	16,950 $2.53 Million
Q1 2019 May 14, 2019	BUY	$28.07 - $38.18 $129,122 - $175,628	4,600 Added 46.46%	14,500 $1.73 Million
Q4 2018 Jan 14, 2019	BUY	$26.99 - $37.37 $267,201 - $369,963	9,900 New	9,900 $1.19 Million

Others Institutions Holding DXCM

# of Institutions

1,014

Shares Held

351M

Call Options Held

5.51M

Put Options Held

5.6M

View Full List

About DEXCOM INC

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $30.9B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

More about DXCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sit Investment Associates Inc, based on Form 13F filings with the SEC.

News

Stay updated on Sit Investment Associates Inc with notifications on news.

Account

Sit Investment Associates Inc Dexcom Inc Transaction History